Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct;96(4):802-811.
doi: 10.1002/ana.27030. Epub 2024 Aug 2.

Multiple Acyl-Coenzyme A Dehydrogenase Deficiency Is Associated with Sertraline Use - Is There an Acquired Form?

Sofie Sunebo  1 , Hanna Appelqvist  1 , Bo Häggqvist  1 , Olof Danielsson  1
Affiliations

Multiple Acyl-Coenzyme A Dehydrogenase Deficiency Is Associated with Sertraline Use - Is There an Acquired Form?

Sofie Sunebo et al. Ann Neurol. 2024 Oct.

Abstract

Objective: Multiple acyl-coenzyme A dehydrogenase deficiency (MADD) is a disorder of fatty acid oxidation and considered an inborn error of metabolism. In recent years, we have diagnosed an increasing number of patients where, despite extensive investigation, no disease-causing mutations have been found. We therefore investigated a cohort of consecutive patients, with the objective to detect possible non-genetic causes.

Methods: We searched the patient records and the registry of muscle biopsies, for patients with MADD, diagnosed within the past 10 years. The patient records were reviewed regarding symptoms, clinical findings, comorbidities, drugs, diagnostic investigations, and response to treatment. In addition, complementary investigations of muscle tissue were performed.

Results: We identified 9 patients diagnosed with late-onset MADD. All presented with muscle weakness and elevated levels of creatine kinase. A lipid storage myopathy was evident in the muscle biopsies, as was elevated acylcarnitines in blood. Despite thorough genetic investigations, a probable genetic cause was found in only 2 patients. Remarkably, all 7 patients without disease-causing mutations were treated with sertraline. In some cases, a deterioration of symptoms closely followed dose increase, and discontinuation resulted in an improved acylcarnitine profile. All 9 patients responded to riboflavin treatment with normalization of creatine kinase and muscle biopsy findings, and in 8 patients the clinical symptoms clearly improved.

Interpretation: Our findings strongly suggest that sertraline may induce an acquired form of MADD in some patients. Importantly, riboflavin treatment seems to be similarly effective as in genetic MADD, but discontinuation of sertraline is reasonably warranted. ANN NEUROL 2024;96:802-811.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Wen B, Tang S, Lv X, et al. Clinical, pathological and genetic features and follow‐up of 110 patients with late‐onset MADD: a single‐center retrospective study. Hum Mol Genet 2022;31:1115–1129.
    1. Schulze A, Lindner M, Kohlmuller D, et al. Expanded newborn screening for inborn errors of metabolism by electrospray ionization‐tandem mass spectrometry: results, outcome, and implications. Pediatrics 2003;111:1399–1406.
    1. Kuo YC, Hsueh HW, Hsueh SJ, et al. A systematic review of late‐onset and very‐late‐onset multiple acyl‐coenzyme a dehydrogenase deficiency: cohort analysis and patient report from Taiwan. Neuromuscul Disord 2021;31:218–225.
    1. Mereis M, Wanders RJA, Schoonen M, et al. Disorders of flavin adenine dinucleotide metabolism: MADD and related deficiencies. Int J Biochem Cell Biol 2021;132:105899.
    1. Fu HX, Liu XY, Wang ZQ, et al. Significant clinical heterogeneity with similar ETFDH genotype in three Chinese patients with late‐onset multiple acyl‐CoA dehydrogenase deficiency. Neurol Sci 2016;37:1099–1105.

LinkOut - more resources